Therefore, we hypothesize that tumor-associated MSC-2 populations is the mediator of the bone remodeling observed in ccRCC bone metastasis patients through the channel of RANKL-RANK/OPG signaling. The gene discussed is TNFSF11; the disease is nonpapillary renal cell carcinoma.